2 weeks Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise Seeking Alpha Gilead Sciences: 2025 Preview, A Buy Thanks To Thriving HIV Franchise. Gilead (GILD) X
1 week Gilead Sciences (GILD) Stock Declines While Market Improves: Some Information for Investors Zacks X
2 weeks Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know Zacks X
2 weeks Here’s How You Can Earn $100 In Passive Income By Investing In Gilead Sciences Stock Yahoo Finance X
3 weeks Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains Zacks X
1 month The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks X
1 month Gilead Sciences, Inc. (GILD) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) Seeking Alpha X
1 month Gilead Sciences, Inc. (GILD) Piper Sandler 36th Annual Healthcare Conference (Transcript) Seeking Alpha X
2 months Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference (Transcript) Seeking Alpha X
2 months Gilead Sprints To A Profit-Taking Zone After Riding Covid Drug To Beat And Raise Investor's Business Daily X
2 months Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidance MarketWatch X
2 months Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by New York State Teachers Retirement System MarketBeat X
2 months Gilead Sciences (NASDAQ:GILD) Given Sector Perform Rating at Royal Bank of Canada MarketBeat X
3 months Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of “Moderate Buy” by Brokerages MarketBeat X
3 months Crew Capital Management Ltd. Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD) MarketBeat X